UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:June 08,
Oncocyte (NASDAQ:OCX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Oncocyte Charts.
Oncocyte (NASDAQ:OCX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Oncocyte Charts.

Oncocyte Corp News

PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace
Tuesday 7 May 2024 (1 day ago) • GlobeNewswire Inc.
Oncocyte Reports Full Year 2023 Financial Results
Friday 12 April 2024 (4 weeks ago) • GlobeNewswire Inc.
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
Friday 12 April 2024 (4 weeks ago) • GlobeNewswire Inc.
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
Friday 12 April 2024 (4 weeks ago) • GlobeNewswire Inc.
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results
Wednesday 10 April 2024 (4 weeks ago) • GlobeNewswire Inc.
Form 8-K - Current report
Wednesday 24 January 2024 (3 months ago) • Edgar (US Regulatory)
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico
Wednesday 17 January 2024 (4 months ago) • GlobeNewswire Inc.
Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays
Thursday 7 December 2023 (5 months ago) • GlobeNewswire Inc.
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 10 November 2023 (6 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 9 November 2023 (6 months ago) • Edgar (US Regulatory)
Oncocyte Reports Third Quarter 2023 Financial Results
Thursday 9 November 2023 (6 months ago) • GlobeNewswire Inc.
Oncocyte to Announce Third Quarter 2023 Financial Results
Friday 3 November 2023 (6 months ago) • GlobeNewswire Inc.

More Oncocyte Corp News Articles